Status:
UNKNOWN
RF in the Treatment OAB in UUI- a Prospective Randomized Placebo Controlled Study
Lead Sponsor:
Ginekologija Dr. Franić, D.O.O.
Conditions:
Overactive Bladder Syndrome
Urge Incontinence
Eligibility:
FEMALE
30-80 years
Phase:
NA
Brief Summary
Until now, OAB with or without UUI has been treated mainly in two ways: with behavioral methods and/or patient education or using antimuscarinic drugs and/or beta 3 adrenergic receptor agonists. Unfor...
Detailed Description
Criteria for inclusion in the study Women who have clear signs of OAB was included in the study. Also, those women who did not use drugs for the treatment of OAB (antimuscarinics/beta-3 agonists), wer...
Eligibility Criteria
Inclusion
- clear signs of OAB
- did not use drugs for the treatment of OAB (antimuscarinics/beta-3 agonists)
- women who have taken drugs for the treatment of OAB in the past, but stopped at least 3 months prior the entering the study.
Exclusion
- Inserted heart pacemaker,
- unexplained bleeding from the vagina,
- inflammation of the vagina and/or uterus or uterine appendages.
- Bacterial or viral infection,
- weakened immune system,
- sclerodermia,
- radiation treatment,
- burns in the treatment area,
- stress urinary incontinence (SUI) or mixed urinary incontinence
Key Trial Info
Start Date :
July 10 2023
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
March 31 2024
Estimated Enrollment :
80 Patients enrolled
Trial Details
Trial ID
NCT06080217
Start Date
July 10 2023
End Date
March 31 2024
Last Update
December 1 2023
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Damir Franić
Rogaška Slatina, Slovenia, 3250
2
Outpatient Clinic Ob&Gyn
Rogaška Slatina, Slovenia, 3250